This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Sep 20;367(12):1165-6; author reply 1166-7.

doi: 10.1056/NEJMc1208803.

Review of novel therapeutics by three regulatory agencies

Tetsuya Tanimoto, Eiji Kusumi, Shunsuke Ono

PMID: 22992090
DOI: 10.1056/NEJMc1208803

Comment

Review of novel therapeutics by three regulatory agencies

Tetsuya Tanimoto et al. N Engl J Med. 2012.

. 2012 Sep 20;367(12):1165-6; author reply 1166-7.

doi: 10.1056/NEJMc1208803.

Authors

Tetsuya Tanimoto, Eiji Kusumi, Shunsuke Ono

PMID: 22992090
DOI: 10.1056/NEJMc1208803

No abstract available

PubMed Disclaimer

Comment on

Regulatory review of novel therapeutics--comparison of three regulatory agencies.
Downing NS, Aminawung JA, Shah ND, Braunstein JB, Krumholz HM, Ross JS. Downing NS, et al. N Engl J Med. 2012 Jun 14;366(24):2284-93. doi: 10.1056/NEJMsa1200223. Epub 2012 May 16. N Engl J Med. 2012. PMID: 22591257 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.